Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clascoterone vs Clindamycin as Adjunct to Adapalene/BPO in Moderate Facial Acne
NCT07881315Phase 4Not yet recruiting
- Sponsor
- Allied Hospital Faisalabad
- Start
- Nov 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of clascoterone in acne vulgaris (2 arms), sponsored by Allied Hospital Faisalabad. Primary endpoint: Percentage change in inflammatory lesion count at 12 weeks. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT07881315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07881315.